ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 671,34
1,34%
Dow Jones
39 134,76
0,77%
DAX
18 254,18
1,03%
Brent Oil
85,005
0,37%
Bitcoin
64 900,49
-0,10%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Inhibitex, Inc. (MM) (INHX)

  7. Inhibitex, Inc. (MM) (INHX) Actualités

INHX

Inhibitex, Inc. (MM) (INHX)

Inhibitex, Inc. (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:INHX
DateHeureSourceTitreSymboleSociété
13/02/201217h55Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:INHXInhibitex, Inc. (MM)
13/02/201214h22Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:INHXInhibitex, Inc. (MM)
13/02/201212h03Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:INHXInhibitex, Inc. (MM)
09/02/201219h13Edgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:INHXInhibitex, Inc. (MM)
07/02/201215h00MarketwiredA Forward Look, the Year Ahead - Featured Research on Inhibitex, Inc. and Idenix Pharmaceuticals, Inc.NASDAQ:INHXInhibitex, Inc. (MM)
06/02/201214h18Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:INHXInhibitex, Inc. (MM)
03/02/201221h09Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INHXInhibitex, Inc. (MM)
26/01/201218h32Dow Jones NewsUPDATE: Bristol-Myers 4Q Net Up 76% On Lower Taxes But Results Miss ViewsNASDAQ:INHXInhibitex, Inc. (MM)
26/01/201215h11Dow Jones NewsBristol-Myers 4Q Net Up 76% On Lower Taxes But Results Miss ViewsNASDAQ:INHXInhibitex, Inc. (MM)
26/01/201214h56ZacksBristol-Myers Misses on All Fronts - Analyst BlogNASDAQ:INHXInhibitex, Inc. (MM)
23/01/201210h00ZacksEarnings Preview: Bristol-Myers - Analyst BlogNASDAQ:INHXInhibitex, Inc. (MM)
20/01/201209h30ZacksThe Zacks Analyst Blog Highlights: Gilead Sciences, Bristol-Myers Squibb, Inhibitex, Vertex Pharmaceuticals & Merck - Press R..NASDAQ:INHXInhibitex, Inc. (MM)
19/01/201214h15ZacksGilead Clinches Pharmasset Buy - Analyst BlogNASDAQ:INHXInhibitex, Inc. (MM)
17/01/201222h37Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:INHXInhibitex, Inc. (MM)
17/01/201212h15Edgar (US Regulatory)Statement of Ownership: Solicitation (SC 14D9)NASDAQ:INHXInhibitex, Inc. (MM)
13/01/201222h59Edgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)NASDAQ:INHXInhibitex, Inc. (MM)
13/01/201222h21Edgar (US Regulatory)Tender offer statement by Third Party (SC TO-T)NASDAQ:INHXInhibitex, Inc. (MM)
13/01/201220h07MarketwiredThe Law Firm of Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of Inhibitex, I...NASDAQ:INHXInhibitex, Inc. (MM)
11/01/201217h50PR Newswire (US)Potentially Unfair Tender Offer for Inhibitex Triggers Shareholder-Claim Investigation by Securities Class Action Lawyers at ...NASDAQ:INHXInhibitex, Inc. (MM)
11/01/201202h28Dow Jones NewsMerck Will Consider Deals To Expand Hepatitis C Drug LineupNASDAQ:INHXInhibitex, Inc. (MM)
11/01/201201h06Business WireThe Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Inhibi...NASDAQ:INHXInhibitex, Inc. (MM)
11/01/201201h00Business WireFaruqi & Faruqi, LLP Announces Investigation of Inhibitex, Inc.NASDAQ:INHXInhibitex, Inc. (MM)
10/01/201222h17Edgar (US Regulatory)Current report filing (8-K)NASDAQ:INHXInhibitex, Inc. (MM)
10/01/201221h57Business WireLaw Firm Brower Piven Announces Investigation of Inhibitex, Inc.NASDAQ:INHXInhibitex, Inc. (MM)
10/01/201216h37Business WireRyan & Maniskas, LLP Announces Investigation of Inhibitex, Inc.NASDAQ:INHXInhibitex, Inc. (MM)
10/01/201212h04Edgar (US Regulatory)Written communication relating to an issuer or third party (SC TO-C)NASDAQ:INHXInhibitex, Inc. (MM)
10/01/201209h30ZacksThe Zacks Analyst Blog Highlights: Bristol-Myers Squibb, Sanofi, Inhibitex, Gilead Sciences and Pharmasset - Press ReleasesNASDAQ:INHXInhibitex, Inc. (MM)
10/01/201201h03Business WireLaw Offices of Howard G. Smith Announces Investigation of Inhibitex, Inc.NASDAQ:INHXInhibitex, Inc. (MM)
09/01/201222h02Business WirePomerantz Law Firm Investigates Claims on Behalf of Investors of Inhibitex, Inc.NASDAQ:INHXInhibitex, Inc. (MM)
09/01/201219h10Business WireHarwood Feffer LLP Announces Investigation of Inhibitex, Inc.NASDAQ:INHXInhibitex, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:INHX

Dernières Valeurs Consultées

USOTC
SYBE
SYBLEU (PK)
TSXV
CNY
Cancana Resources Corp.
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés